Managing antithrombotic treatment in a patient with atrial fibrillation and coronary stent with transient neurological symptoms in cerebral amyloid angiopathy

Julie Ravn; Tobias Sejbæk; Mustafa Vakur Bor

doi:10.1002/ccr3.6624

Managing antithrombotic treatment in a patient with atrial fibrillation and coronary stent with transient neurological symptoms in cerebral amyloid angiopathy

Clin Case Rep. 2022 Dec 13;10(12):e6624. doi: 10.1002/ccr3.6624. eCollection 2022 Dec.

Authors

Julie Ravn¹, Tobias Sejbæk^{1

2}, Mustafa Vakur Bor^{3

4}

Affiliations

¹ Department of Neurology University Hospital of Southern Denmark Esbjerg Denmark.
² BRIDGE - Brain Research - Inter-Disciplinary Guided Excellence, Department of Regional Health Research University of Southern Denmark Odense Denmark.
³ Thrombosis Research, Department of Regional Health Research University of Southern Denmark Esbjerg Denmark.
⁴ Thrombosis and Anticoagulation Clinic, Department of Clinical Biochemistry University Hospital of Southern Esbjerg Denmark.

Abstract

We present the antithrombotic dilemma in a case with atrial fibrillation and a coronary stent and suspected transient ischemic attacks after diagnosed as a probable cerebral amyloid angiopathy and discuss plausible treatment options for the patient based on the available evidence.

Keywords: antithrombotic treatment; atrial fibrillation; cerebral amyloid angiopathy.

Publication types

Case Reports